169 related articles for article (PubMed ID: 8627951)
1. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951
[No Abstract] [Full Text] [Related]
2. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Jan; 45(2):29-32. PubMed ID: 8531917
[TBL] [Abstract][Full Text] [Related]
3. Progress in the clinical management of haemophilia.
Bloom AL
Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
[No Abstract] [Full Text] [Related]
4. Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?
Mosley JW
Vox Sang; 1994; 67 Suppl 4():12-5; discussion 24-6. PubMed ID: 7831863
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
6. Virucidal treatment of clotting factor concentrates.
Mannucci PM; Colombo M
Lancet; 1988 Oct; 2(8614):782-5. PubMed ID: 2901620
[No Abstract] [Full Text] [Related]
7. Clotting factors and hepatitis A.
Robinson SM; Schwinn H; Smith A
Lancet; 1992 Dec; 340(8833):1465. PubMed ID: 1360575
[No Abstract] [Full Text] [Related]
8. Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis.
Skidmore SJ; Pasi KJ; Mawson SJ; Williams MD; Hill FG
J Med Virol; 1990 Jan; 30(1):50-2. PubMed ID: 2106006
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
[TBL] [Abstract][Full Text] [Related]
10. Clotting factors and hepatitis A. Working Group on Hepatitis A and Clotting Factors.
Shouval D; Gerlich WH
Lancet; 1992 Dec; 340(8833):1465-6. PubMed ID: 1360576
[No Abstract] [Full Text] [Related]
11. Treatment protocol of haemophilia and other congenital bleeding disorders in Italy. Italian Association of Hemophilia Centers (AICE).
Gringeri A
Haemophilia; 1998 Jul; 4(4):423-4. PubMed ID: 9873767
[No Abstract] [Full Text] [Related]
12. Hemophilia-associated AIDS in the United States, 1981 to September 1987.
Stehr-Green JK; Holman RC; Jason JM; Evatt BL
Am J Public Health; 1988 Apr; 78(4):439-42. PubMed ID: 3126675
[TBL] [Abstract][Full Text] [Related]
13. Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion.
Evensen SA; Rollag H
Lancet; 1993 Apr; 341(8850):971-2. PubMed ID: 8096316
[No Abstract] [Full Text] [Related]
14. An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source.
Kedda MA; Kew MC; Cohn RJ; Field SP; Schwyzer R; Song E; Fernandes-Costa F
Hepatology; 1995 Nov; 22(5):1363-7. PubMed ID: 7590648
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic properties and safety of recombinant factor VIII and factor IX.
Zdziarska J; Chojnowski K; Klukowska A; Łetowska M; Mital A; Podolak-Dawidziak M; Windyga J; Zawilska K;
Pol Arch Med Wewn; 2009 Jun; 119(6):403-9. PubMed ID: 19694223
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A virus infections associated with clotting factor concentrate in the United States.
Soucie JM; Robertson BH; Bell BP; McCaustland KA; Evatt BL
Transfusion; 1998 Jun; 38(6):573-9. PubMed ID: 9661691
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
18. Clotting factors and hepatitis A.
Temperley IJ; Cotter KP; Walsh TJ; Power J; Hillary IB
Lancet; 1992 Dec; 340(8833):1466. PubMed ID: 1360577
[No Abstract] [Full Text] [Related]
19. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH
Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424
[TBL] [Abstract][Full Text] [Related]
20. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease.
Kreuz W; Klarmann D; Auerswald G; Auberger K; Gürtler L; Rabenau H; Doerr WD
Lancet; 1993 Feb; 341(8842):446. PubMed ID: 8094219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
